Ind-Swift, 524652, INDSWFTLTD Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

57.85
N/A
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,051.40
N/A
-0.08

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
6.24
7.20

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
30.94

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-39.38
-

P:E (Median)

8 Years
5 Years
3 Years

P:BV (Average)

8 Years
5 Years
3 Years

-0.06
-0.06
-0.06

EV:EBITDA (Average)

8 Years
5 Years
3 Years

16.53
28.36
29.36

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 22 Mar 21 Var% Dec 21 Dec 20 Var% Sep 21 Sep 20 Var% Jun 21 Jun 20 Var%
Net Sales 105.57 94.01 12.30% 104.35 104.75 -0.38% 97.38 95.98 1.46% 90.42 61.31 47.48%
Expenses 95.59 94.50 1.15% 92.32 87.23 5.84% 84.69 81.34 4.12% 79.77 51.60 54.59%
EBITDA 9.98 -0.49 - 12.03 17.52 -31.34% 12.69 14.63 -13.26% 10.65 9.71 9.68%
EBIDTM 9.45% -0.52% 11.53% 16.73% 13.03% 15.25% 11.78% 15.84%
Other Income 7.08 5.74 23.34% 2.81 1.37 105.11% 5.62 2.40 134.17% 6.05 2.75 120.00%
Interest 14.24 12.89 10.47% 13.63 11.89 14.63% 15.30 11.20 36.61% 12.01 13.23 -9.22%
Depreciation 8.30 8.30 0.00% 7.99 8.18 -2.32% 7.95 8.13 -2.21% 7.83 8.10 -3.33%
PBT -5.48 -17.15 - -6.04 -1.19 - -4.94 -2.29 - -3.15 -8.86 -
Tax 0.00 0.32 -100.00% 0.00 0.00 0 0.00 0.00 0 0.42 0.00 0
PAT -5.48 -17.47 - -6.04 -1.19 - -4.94 -2.29 - -3.57 -8.86 -
PATM -5.19% -18.59% -5.78% -1.14% -5.07% -2.39% -3.95% -14.45%
EPS -1.01 -3.22 - -1.11 -0.22 - -0.91 -0.42 - -0.66 -1.64 -

Description Mar 22 Mar 21 Var% Dec 21 Dec 20 Var% Sep 21 Sep 20 Var% Jun 21 Jun 20 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Jun 12
Net Sales 397.72 356.06 329.52 289.03 269.81 263.05 304.33 417.17 569.80 393.12 1,590.47 Net Sales Growth 11.70% 8.05% 14.01% 7.12% 2.57% -13.56% -27.05% -26.79% 44.94% -75.28% Cost Of Goods Sold 211.03 186.53 187.73 159.95 154.15 166.03 220.48 353.43 458.49 287.85 1,357.33 Gross Profit 186.69 169.53 141.79 129.08 115.66 97.03 83.85 63.74 111.31 105.27 233.13 GP Margin 46.94% 47.61% 43.03% 44.66% 42.87% 36.89% 27.55% 15.28% 19.53% 26.78% 14.66% Total Expenditure 352.37 314.68 306.18 278.28 263.52 328.46 461.28 487.10 603.92 415.52 1,499.42 Power & Fuel Cost - 9.34 12.40 13.00 11.10 10.43 10.89 11.80 13.57 9.07 11.94 % Of Sales - 2.62% 3.76% 4.50% 4.11% 3.97% 3.58% 2.83% 2.38% 2.31% 0.75% Employee Cost - 51.17 48.93 46.33 44.67 38.79 36.77 39.27 45.13 40.82 39.48 % Of Sales - 14.37% 14.85% 16.03% 16.56% 14.75% 12.08% 9.41% 7.92% 10.38% 2.48% Manufacturing Exp. - 20.76 16.04 14.45 12.93 9.53 8.58 11.67 26.39 20.37 25.90 % Of Sales - 5.83% 4.87% 5.00% 4.79% 3.62% 2.82% 2.80% 4.63% 5.18% 1.63% General & Admin Exp. - 30.14 30.98 26.37 25.28 63.95 50.40 25.18 24.69 23.04 26.40 % Of Sales - 8.46% 9.40% 9.12% 9.37% 24.31% 16.56% 6.04% 4.33% 5.86% 1.66% Selling & Distn. Exp. - 9.97 7.31 6.83 3.15 3.50 4.16 11.47 19.83 18.35 10.06 % Of Sales - 2.80% 2.22% 2.36% 1.17% 1.33% 1.37% 2.75% 3.48% 4.67% 0.63% Miscellaneous Exp. - 6.78 2.79 11.35 12.23 36.24 130.01 34.29 15.83 16.02 10.06 % Of Sales - 1.90% 0.85% 3.93% 4.53% 13.78% 42.72% 8.22% 2.78% 4.08% 1.78% EBITDA 45.35 41.38 23.34 10.75 6.29 -65.41 -156.95 -69.93 -34.12 -22.40 91.05 EBITDA Margin 11.40% 11.62% 7.08% 3.72% 2.33% -24.87% -51.57% -16.76% -5.99% -5.70% 5.72% Other Income 21.56 15.22 22.38 8.44 14.57 13.68 12.51 1.87 12.80 6.34 29.32 Interest 55.18 52.18 35.19 3.77 11.46 16.32 18.97 39.93 76.76 86.41 120.97 Depreciation 32.07 32.70 33.59 33.97 34.63 35.73 36.35 39.36 26.26 18.48 23.25 PBT -19.61 -28.29 -23.06 -18.55 -25.23 -103.77 -199.77 -147.36 -124.34 -120.94 -23.85 Tax 0.42 0.32 2.46 0.00 0.75 0.89 0.17 -2.23 -8.77 -9.65 -2.84 Tax Rate -2.14% -1.08% -14.77% 0.00% -1.41% -0.24% -0.09% 1.51% 7.05% 7.98% 11.91% PAT -20.03 -29.82 -19.12 8.19 -54.13 -364.27 -199.94 -145.13 -115.56 -111.29 -21.02 PAT before Minority Interest -20.03 -29.82 -19.12 8.19 -54.13 -364.27 -199.94 -145.13 -115.56 -111.29 -21.02 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -5.04% -8.37% -5.80% 2.83% -20.06% -138.48% -65.70% -34.79% -20.28% -28.31% -1.32% PAT Growth 0.00% - - - - - - - - - EPS -3.70 -5.50 -3.53 1.51 -9.99 -67.21 -36.89 -26.78 -21.32 -20.53 -3.88

Description TTM Mar 18 Mar 17 Mar 16
Net Sales - 269.81 263.05 304.33 Net Sales Growth - 2.57% -13.56% Cost Of Goods Sold - 154.15 166.03 220.48 Gross Profit - 115.66 97.03 83.85 GP Margin - 42.87% 36.89% 27.55% Total Expenditure - 263.52 328.46 461.28 Power & Fuel Cost - 11.10 10.43 10.89 % Of Sales - 4.11% 3.97% 3.58% Employee Cost - 44.67 38.79 36.77 % Of Sales - 16.56% 14.75% 12.08% Manufacturing Exp. - 12.93 9.53 8.58 % Of Sales - 4.79% 3.62% 2.82% General & Admin Exp. - 25.28 63.95 50.40 % Of Sales - 9.37% 24.31% 16.56% Selling & Distn. Exp. - 3.15 3.50 4.16 % Of Sales - 1.17% 1.33% 1.37% Miscellaneous Exp. - 12.23 36.24 130.01 % Of Sales - 4.53% 13.78% 42.72% EBITDA - 6.29 -65.41 -156.95 EBITDA Margin - 2.33% -24.87% -51.57% Other Income - 14.57 13.68 12.51 Interest - 11.46 16.32 18.97 Depreciation - 34.63 35.73 36.35 PBT - -25.23 -103.77 -199.77 Tax - 0.75 0.89 0.17 Tax Rate - -1.41% -0.24% -0.09% PAT - -54.13 -364.27 -199.94 PAT before Minority Interest - -54.13 -364.27 -199.94 Minority Interest - 0.00 0.00 0.00 PAT Margin - -20.06% -138.48% -65.70% PAT Growth - - - EPS - -9.99 -67.21 -36.89

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Jun 12
Shareholder's Funds -695.16 -713.12 -676.74 -679.37 -611.01 -239.48 -39.50 108.38 217.30 321.08 Share Capital 10.83 10.83 10.83 10.83 25.03 24.27 24.27 24.27 23.44 23.44 Total Reserves -706.00 -723.95 -687.57 -690.20 -636.04 -270.43 -70.45 77.43 186.57 294.64 Non-Current Liabilities 660.58 660.64 659.29 693.89 672.22 679.33 549.04 595.58 609.48 301.28 Secured Loans 629.97 624.94 620.34 651.65 644.57 647.04 507.75 542.99 556.26 232.03 Unsecured Loans 14.20 19.28 24.34 29.54 20.20 24.61 33.66 42.11 34.37 40.56 Long Term Provisions 9.04 8.72 7.36 5.66 2.64 2.04 1.40 1.60 0.96 0.61 Current Liabilities 706.16 654.13 615.87 598.24 607.85 620.93 718.29 685.84 580.56 945.80 Trade Payables 232.02 226.22 198.83 180.12 161.76 175.38 150.26 191.35 140.96 334.43 Other Current Liabilities 98.28 57.34 53.16 44.08 62.57 74.30 199.01 147.45 87.41 165.24 Short Term Borrowings 375.86 370.56 363.88 374.04 383.52 371.25 369.02 347.05 352.19 446.13 Short Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Total Liabilities 671.58 601.65 598.42 612.76 669.06 1,060.78 1,227.83 1,389.80 1,407.34 1,568.16 Net Block 244.01 269.66 290.56 310.68 342.31 374.14 403.66 440.12 420.66 396.22 Gross Block 607.42 601.49 589.92 576.33 576.38 572.52 565.68 559.58 513.99 473.17 Accumulated Depreciation 363.41 331.83 299.37 265.65 234.06 198.37 162.02 119.45 93.33 76.95 Non Current Assets 406.40 373.00 404.91 426.66 462.63 439.25 468.93 505.95 519.41 526.63 Capital Work in Progress 13.06 0.00 0.00 0.00 2.22 3.67 3.89 4.44 36.85 49.32 Non Current Investment 70.31 24.06 41.26 43.91 43.90 45.12 45.12 45.19 45.19 45.57 Long Term Loans & Adv. 79.02 79.27 73.09 72.06 74.19 16.31 16.26 16.20 16.71 35.50 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 265.17 228.65 193.51 186.11 206.43 611.65 737.94 851.09 842.83 986.18 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 62.85 52.41 49.00 45.44 39.06 90.94 113.37 253.36 329.46 365.53 Sundry Debtors 107.95 94.17 75.56 83.50 108.48 380.33 485.48 440.14 363.98 450.27 Cash & Bank 28.99 16.76 19.72 3.68 9.11 17.39 16.98 17.90 17.79 45.60 Other Current Assets 65.39 19.05 2.07 2.01 49.78 122.98 122.11 139.70 131.60 124.78 Short Term Loans & Adv. 45.91 46.27 47.17 51.48 42.81 109.93 108.90 123.33 115.90 111.32 Net Current Assets -440.99 -425.48 -422.36 -412.13 -401.42 -9.29 19.65 165.25 262.27 40.38 Total Assets 671.57 601.65 598.42 612.77 669.06 1,060.79 1,227.83 1,389.81 1,407.36 1,568.16

Description Mar 18 Mar 17 Mar 16
Shareholder's Funds -663.18 -615.50 -245.43 Share Capital 25.03 25.03 24.27 Total Reserves -688.21 -640.54 -276.38 Non-Current Liabilities 679.69 672.22 679.33 Secured Loans 651.65 644.57 647.04 Unsecured Loans 15.34 20.20 24.61 Long Term Provisions 5.66 2.64 2.04 Current Liabilities 598.24 607.85 620.93 Trade Payables 166.30 161.76 175.38 Other Current Liabilities 57.90 62.57 74.30 Short Term Borrowings 374.04 383.52 371.25 Short Term Provisions 0.00 0.00 0.00 Total Liabilities 614.75 664.57 1,054.83 Net Block 310.68 342.31 374.14 Gross Block 576.33 576.38 572.52 Accumulated Depreciation 265.65 234.06 198.37 Non Current Assets 428.64 458.13 433.29 Capital Work in Progress 0.00 2.22 3.67 Non Current Investment 45.90 39.41 39.17 Long Term Loans & Adv. 72.06 74.19 16.31 Other Non Current Assets 0.00 0.00 0.00 Current Assets 186.11 206.43 611.65 Current Investments 0.00 0.00 0.00 Inventories 45.44 39.06 90.94 Sundry Debtors 83.50 108.48 380.33 Cash & Bank 3.68 9.11 17.39 Other Current Assets 53.49 6.97 13.05 Short Term Loans & Adv. 47.82 42.81 109.93 Net Current Assets -412.13 -401.42 -9.29 Total Assets 614.75 664.56 1,054.83

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Jun 12
Cash From Operating Activity 77.24 34.60 42.79 1.34 6.72 -105.79 85.57 102.73 -146.30 94.09 PBT -29.82 -19.12 8.19 -53.38 -363.37 -199.77 -147.36 -124.34 -120.94 -23.85 Adjustment 83.38 52.68 21.32 73.12 321.14 168.51 90.75 107.10 112.62 148.84 Changes in Working Capital 23.68 1.03 13.27 -18.41 48.95 -74.54 142.19 120.11 -138.18 -27.42 Cash after chg. in Working capital 77.24 34.60 42.79 1.34 6.72 -105.79 85.57 102.87 -146.50 97.57 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.13 0.20 -3.48 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -16.71 -11.35 -13.71 -2.73 -4.30 -4.01 -5.52 -13.76 -27.72 -184.44 Net Fixed Assets -18.99 -11.57 -13.59 2.27 -2.41 -6.62 -5.55 -13.18 -28.35 -138.52 Net Investments -46.25 17.20 2.65 -0.01 1.22 0.00 0.07 0.00 0.38 0.00 Others 48.53 -16.98 -2.77 -4.99 -3.11 2.61 -0.04 -0.58 0.25 -45.92 Cash from Financing Activity -48.30 -26.20 -13.03 -4.04 -10.71 110.21 -80.97 -88.87 146.22 99.17 Net Cash Inflow / Outflow 12.23 -2.96 16.05 -5.43 -8.28 0.41 -0.91 0.11 -27.81 8.82 Opening Cash & Equivalents 16.76 19.72 3.68 9.11 17.39 16.98 17.90 17.79 45.60 36.78 Closing Cash & Equivalent 28.99 16.76 19.72 3.68 9.11 17.39 16.98 17.90 17.79 45.60

Description Mar 18 Mar 17 Mar 16
Cash From Operating Activity 7.17 -1.72 -119.44 PBT -50.43 -371.81 -213.42 Adjustment 73.87 321.14 168.51 Changes in Working Capital -16.28 48.95 -74.54 Cash after chg. in Working capital 7.17 -1.72 -119.44 Interest Paid 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity -6.42 4.14 9.64 Net Fixed Assets 2.27 -2.41 Net Investments -0.01 1.22 Others -8.68 5.33 Cash from Financing Activity -6.17 -10.71 110.21 Net Cash Inflow / Outflow -5.43 -8.28 0.41 Opening Cash & Equivalents 9.11 17.39 16.98 Closing Cash & Equivalent 3.68 9.11 17.39

Financial Ratios

Standalone /

Consolidated

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Jun 12
Book Value (Rs.) -128.34 -131.66 -124.94 -125.43 -115.43 -53.68 -16.16 10.87 32.63 53.82 ROA -4.68% -3.19% 1.35% -8.45% -42.12% -17.47% -11.09% -8.26% -7.48% -1.50% ROE 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -112.51% -55.75% -7.76% ROCE 7.19% 5.82% 3.37% -10.31% -56.22% -20.35% -10.41% -4.27% -3.10% 9.75% Fixed Asset Turnover 0.61 0.57 0.50 0.47 0.47 0.54 0.75 1.07 0.80 4.35 Receivable days 100.13 91.72 100.44 129.49 333.86 513.44 400.24 255.51 374.10 77.96 Inventory Days 57.10 54.80 59.63 56.99 88.79 121.16 158.57 185.19 319.31 95.72 Payable days 448.35 247.87 248.96 230.73 227.19 184.88 167.49 116.11 212.80 73.69 Cash Conversion Cycle -291.13 -101.35 -88.90 -44.24 195.46 449.72 391.32 324.59 480.61 99.99 Total Debt/Equity -1.47 -1.43 -1.49 -1.55 -1.72 -4.09 -15.49 14.65 5.89 3.12 Interest Cover 0.43 0.53 3.18 -3.66 -21.27 -9.53 -2.69 -0.62 -0.40 0.80

Description Mar 18 Mar 17 Mar 16
Book Value (Rs.) -125.06 -116.26 -54.86 ROA -8.46% -42.37% -18.95% ROE 0.00% 0.00% 0.00% ROCE -10.34% -56.70% -22.84% Fixed Asset Turnover 0.47 0.47 0.54 Receivable days 129.49 333.86 451.08 Inventory Days 56.99 88.79 107.86 Payable days 221.40 227.19 199.14 Cash Conversion Cycle -34.91 195.46 359.81 Total Debt/Equity -1.57 -1.70 -4.00 Interest Cover -3.66 -21.27 -9.53

Top Investors:

justin pharmaceuticals private limited

deepa ram kheria

rameshkumar javerchand jain

sharwan singh guleria

gravity systems private limited

panchkula finvest private limited

excel motors private limited

iepf

Annual Reports:

News Update:

Ind-Swift launches cardio diabetic & antibiotic products in Qatar
3rd Jun 2022, 16:26 PM

Ind-Swift is also supplying its products in market of Iraq & Yemen and making available quality products at an affordable price to customers
Read More
Ind-Swift incorporates wholly owned subsidiary company
16th May 2022, 10:00 AM

The object of setting up a wholly owned subsidiary in the Republic of Kenya is to facilitate the promotion of the Company's products in Kenya
Read More

Ind-Swift Ltd.

Pharmaceuticals & Drugs

BSE: 524652 | NSE: INDSWFTLTD

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update:

Ind-Swift Ltd.

Pharmaceuticals & Drugs

BSE: 524652 | NSE: INDSWFTLTD

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update: